Silence Therapeutics Share Price (SLN)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Silence Therapeutics Plc	LSE:SLN	London	Ordinary Share	GB00B9GTXM62	ORD 5P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	9.50	6.40%	158.00	253,265	11:48:08

Bid Price		Offer Price	High Price	Low Price	Open Price
158.00		159.00	160.00	152.00	154.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology		-20.53	-26.20		114

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
11:46:44	AT	32,303	158.00	GBX

Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Bermele (BERM), Valirx (VAL)

Silence Therapeutics (SLN) Latest News (1)

Silence Therapeutics News

Date	Time	Source	Headline
23/7/2019	11:27	UKREG	Silence Therapeutics PLC Additional Listing
19/7/2019	16:35	UKREG	Silence Therapeutics PLC Price Monitoring Extension
19/7/2019	15:13	UKREG	Silence Therapeutics PLC Additional Listing
18/7/2019	13:23	ALNC	Silence Therapeutics Surges As It Signs Major Deal With Mallinckrodt
18/7/2019	11:53	ALNCF	Alliance News Flash Headline
18/7/2019	11:46	PRNUS	Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part..
18/7/2019	11:45	PRNUS	Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And..
16/7/2019	11:46	UKREG	Silence Therapeutics PLC Holding(s) in Company
28/6/2019	14:06	UKREG	Silence Therapeutics PLC Additional Listing
25/6/2019	12:09	UKREG	Silence Therapeutics PLC Result of AGM

More Silence Therapeutics News

Silence Therapeutics Takeover Rumours

Silence Therapeutics (SLN) Share Charts

1 Year Silence Therapeutics Chart

1 Month Silence Therapeutics Chart

Intraday Silence Therapeutics Chart

Silence Therapeutics (SLN) Discussions and Chat

Silence Therapeutics Forums and Chat

Date	Time	Title	Posts
23/7/2019	10:42	Silence Therapeutics (the old SR Pharma)	47,919
06/10/2016	09:04	Gower Productions Presents ....."PREDICTA BID"	52
05/10/2016	20:29	port	-
29/5/2013	10:32	Silence Therapeutics - news and views	1,412
15/2/2013	08:57	SLN - I see no ships, but I do see 10p looming, ahoy!	368

Add a New Thread

Silence Therapeutics (SLN) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
10:46:44	158.00	32,303	51,038.74	AT
10:46:44	158.00	3,051	4,820.58	AT
10:34:24	158.00	3,000	4,740.00	AT
10:32:38	158.00	3,949	6,239.42	AT
10:20:53	158.96	550	874.28	O

View all Silence Therapeutics trades in real-time

Silence Therapeutics (SLN) Top Chat Posts

Date	Subject
23/7/2019 09:20	Silence Therapeutics Daily Update: Silence Therapeutics Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SLN. The last closing price for Silence Therapeutics was 148.50p. Silence Therapeutics Plc has a 4 week average price of 67p and a 12 week average price of 42p. The 1 year high share price is 175p while the 1 year low share price is currently 40p. There are currently 72,163,485 shares in issue and the average daily traded volume is 929,264 shares. The market capitalisation of Silence Therapeutics Plc is £114,018,306.30. Read Full Thread Reply
19/7/2019 15:30	frndlyfire: Eagle is in for a nice surprise when he checks the share price! Well done to all the LT holders here. A lot of pain, but finally something to smile about! Read Full Thread Follow Reply
18/7/2019 13:20	herb clark: Really don't understand why the share price is not higher. Can anyone think any downsides? Read Full Thread Follow Reply
24/4/2019 07:47	tarlok: So we see how much notice the MM make of FT news article on SLN , price change of 1p Read Full Thread Follow Reply
22/3/2019 10:32	tshirley12: A few questions,would appreciate any comments.Firstly over the last year the share price has fallen from a peak of 250p to less than 50p.today.Whilst Arrowheads share price as more or less quadrupled,what is Silence doing that is fundamentally different to justify the crash. What other assets does Silence have other than their.I.P. Is there a danger of Silence running out of funding,and when. As anybody got any idea how much they received from their Alnylam agreement. What happened to ATUO27. As there's no sign of a takeover,are there any possibilities of a merger with anybody. Now waiting on the results from Quark,if this doesn't go as well as hoped, where does that leave us. As I said I would appreciate any comments as I am looking at all avenues before I decide to bail out. Read Full Thread Follow Reply
20/11/2018 08:36	callumross: Well, there is certainly plenty newsflow expected in the next 6 weeks to drive the share price up (or down!). To recap, Quark phase 3 results, High Court case against Alnylam commencing and application for phase 1 trial. Read Full Thread Follow Reply
05/10/2018 17:37	1gw: Interesting to compare the shares on loan position with the share price chart. According to Euroclear, SoL monthly average this year is as follows: 1.4m Jan (average shares on loan) 1.4m Feb 2.6m Mar 4.3m Apr 4.2m May 4.2m Jun 4.1m Jul 3.9m Aug 2.3m Sep So it looks like a significant increase in short positions in March and April (assuming the SoL correlates to short positions) may have helped to knock the shareprice off its 200p perch. hTtps://my.euroclear.com/apps/en/monthly-stock-loan-data.html#month=eq:9&year=eq:2018&limit=0&search=1&order=asc:abbreviation Read Full Thread Follow Reply
03/8/2018 14:10	tshirley12: Could anyone tell me what has happened in the last couple of weeks for the share price to have dropped about 40 points,or nearly 25%. Read Full Thread Follow Reply
06/3/2018 08:32	1gw: I missed the Nasdaq reference at first glance. Interesting. I get the impression this is a management team with more than half an eye focused on the share price and the potential to support the price with the carefully managed release of information. Read Full Thread Follow Reply
24/8/2017 15:24	1gw: I can't help feeling there's an element of SLN investors looking at the ARWR price trajectory and thinking something's happening - and ARWR investors looking at the SLN price trajectory and thinking the same. Hopefully there's some substance behind both moves rather than mutually reinforcing illusions... Read Full Thread Follow Reply
04/5/2017 16:00	1gw: ARWR is up around 20% this afternoon - not enough to take me into profit on my holding, but makes the loss look a little less severe. They beat on revenue and earnings, thanks (I think) to the Amgen up-front payments, and also announced an analyst R&D day for September to explain what they're doing. They described the Amgen partnership as working well and said in response to a question that they were interested in similar partnerships with other companies and are optimistic that they can enter into additional strategic partnerships. No obvious follow-through to the SLN share price yet, but perhaps ARWR's spike (on heavy volume) will draw some attention to other companies in the sector. Read Full Thread Follow Reply

Silence Therapeutics share price data is direct from the London Stock Exchange

Your Recent History

LSE

SLN

Silence Th..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190723 11:05:07